Recent advancements in melanoma management
- PMID: 33738950
- DOI: 10.1111/imj.15228
Recent advancements in melanoma management
Abstract
The treatment options for patients with melanoma have expanded significantly over the past decade. In particular, the use of targeted therapy and immunotherapy has dramatically transformed the outlook for patients with advanced disease. These treatments are now being utilised as adjuvant therapy for patients with earlier stage melanoma after surgical resection. We review the latest updates for melanoma staging, surgical resection, radiotherapy and systemic therapies.
Keywords: immunotherapy; melanoma; targeted therapy.
© 2021 Royal Australasian College of Physicians.
References
- 
    - Australian Institute of Health and Welfare. Cancer Data in Australia, Vol. 2020. Canberra: Australian Institute of Health and Welfare; 2020.
 
- 
    - Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67: 472-92.
 
- 
    - Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014; 370: 599-609.
 
- 
    - Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer NH, Berking C et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol 2019; 37: 3000-8.
 
- 
    - Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 2017; 376: 2211-22.
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
 
        